Feetsee Showcased at Life Sciences Baltics 2025
On September 17–18, Feetsee participated in Life Sciences Baltics 2025 in Vilnius — the leading life sciences forum in the Baltics and one of the region’s key gatherings for health innovation.
This year’s event brought together more than 1,000 participants from 25+ countries, hosted over 500 B2B meetings, featured 100+ speakers, and showcased 70+ exhibitors.
Feetsee joined the exhibition floor to present its contactless medical device for early inflammation detection — an innovation designed to transform diabetic foot care by helping prevent ulcers before they develop.
The Feetsee team was represented by CEO Rytis Zajanckauskas, CBDO Viktorija Lape, CTO Ramunas Valancius, and PM Rokas Ribinskas, who welcomed visitors at the booth and engaged with potential partners, investors, and global health leaders.
Selected to pitch in the event’s Pitch Battle, CEO Rytis Zajanckauskas presented Feetsee’s breakthrough technology to an international jury of investors and industry experts — further raising visibility for Lithuania’s medtech ecosystem on a global stage.
We thank everyone who visited our stand, joined the discussions, and supported our journey. Life Sciences Baltics 2025 has left us inspired and ready to take the next steps toward transforming diabetic foot care.





Detect Early, Prevent Amputations
Diabetic foot ulcers (DFUs) lead to significant discomfort, pain, numerous amputations, and billions of dollars in healthcare costs each year.